With regards to a possible takeover of BPL by Beecham, Peter Wormland of the DHSS stated that was important to reach a decision in principle regarding whether they should reject the commercial option or decide whether they intend to implement it, subject to negations, highlighting issues with further delays to a decision.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Self-Sufficiency